Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERL080 versus CellCept in Chinese Kidney Transplant Recipients
CTR20131879Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate sodium in Kidney allograft status (RTx), sponsored by Novartis. Started Aug 2014; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on CTR20131879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131879.